5 Papers
11 Citations
Jing Xia is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome?
TL;DR: Piezo2 is a candidate biomarker for visceral hypersensitivity in IBS based on expression levels in the intestinal epithelial cells from different intestinal segments and the correlation between Piezo proteins expression and visceral pain threshold.
35
Diagnostic performance of confocal laser endomicroscopy for atrophy and gastric intestinal metaplasia: A meta-analysis.
Tao Bai,Lei Zhang,Stuti Sharma,Yu Dong Jiang,Jing Xia,Huan Wang,Wei Qian,Jun Song,Xiao Hua Hou +8 more
TL;DR: To systematically evaluate the diagnostic efficacy of confocal laser endomicroscopy for gastric atrophy and gastric intestinal metaplasia, a large number of patients with these conditions are diagnosed with either GA or GIM.
14
Cancer‐cell‐biomimetic nanoparticles for enhanced prostate cancer therapy
TL;DR: In this article , a tumor cell membrane-coated nanoplatform (TCM/SCM/DTX) was fabricated for evading the clearance of the immune system and efficiently targeting tumor tissues.
4
Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey
TL;DR: The aims of this study were to investigate the proportion of clinical irritable bowel syndrome at a tertiary hospital in China, to compare the Rome III and Rome IV criteria with regard to IBS diagnosis, to describe the agreement between the Rome II and Rome III criteria, and to identify differences between Rome IV‐positive and ‐negative IBS patients.
Hepatocyte TGF‐β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let‐7b‐5p
Jinfang Zhao,Lilin Hu,Wenfang Gui,Li Xiao,Weijun Wang,Jing Xia,Huiqian Fan,Zhong Lin Li,Qingjing Zhu,Xiaohua Hou,Huikuan Chu,Ekihiro Seki,Lin Yang +12 more
TL;DR: Hepatocyte TGF‐β‐let‐7b‐5p signaling promotes HFD‐induced steatosis and obesity by reducing mitochondrial oxidative phosphorylation and suppressing white‐to‐beige fat conversion.